MRC1 and Marinesco-Sjogren syndrome: Pharmacists can develop inhibitors that target the MMR genes, especially MSH6. These drugs may be used to treat refractory or metastatic advanced MSS/pMMR solid tumors, or they can be combined with ICIs to improve their reactivity in MSI-H/dMMR solid tumors.